Makemytrip Limited (MMYT) 21.78 $MMYT MakeMyTrip Limited

New Post Public Reply Private Reply Replies (0) Message Board

Sep 23, 2016 at 5:17 AM

Makemytrip Limited (MMYT) 21.78 $MMYT

MakeMyTrip Limited Announces Details of Annual Meeting of Shareholders
Globe Newswire - Tue Sep 06, 3:15PM CDT
New Delhi and New York, September 6, 2016: MakeMyTrip Limited (NASDAQ: MMYT) (the "Company"

, India's largest online travel company and the parent company of MakeMyTrip (India) Private Limited, MakeMyTrip Inc., Hotel Travel Group, Luxury Tours & Travel Pte Ltd, ITC Group (Thailand), Luxury Tours (Malaysia) Sdn Bhd and MakeMyTrip FZ-LLC (UAE), announced today that the annual meeting of its shareholders will be held on Friday, September 28, 2016, beginning at 5:00 pm, Indian local time, at Tower A, SP Infocity, 243, Udyog Vihar, Phase 1, Gurgaon, Haryana 122016, India. The Company's notice of annual meeting and form of proxy were issued on September 05, 2016.
MMYT: 21.78 (+0.43)

MakeMyTrip Limited to Present at the Citi 2016 Global Technology Conference
Globe Newswire - Wed Aug 31, 10:00AM CDT
New Delhi and New York, August 31, 2016 MakeMyTrip Limited (NASDAQ: MMYT), India's leading online travel company, announced today that its Co-Founder and CEO India Rajesh Magow will be presenting at the Citi 2016 Technology Conference in New York City on Wednesday, September 7, 2016 at 1:25 pm Eastern Daylight Time.
MMYT: 21.78 (+0.43)

MakeMyTrip (MMYT): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:01AM CDT
MakeMyTrip Limited (MMYT) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
MMYT: 21.78 (+0.43)

MakeMyTrip Limited Reschedules Fiscal 2016 Fourth Quarter and Full Year Financial and Operating Results by One Day
Globe Newswire - Thu May 05, 12:31PM CDT
MakeMyTrip Limited Reschedules Fiscal 2016 Fourth Quarter and Full Year
MMYT: 21.78 (+0.43)

Will Expedia (EXPE) Beat 1Q Earnings Estimates?
Sejuti Banerjea - Zacks Investment Research - Fri Apr 22, 11:36AM CDT
Expedia (EXPE) is slated to report first quarter earnings results on Apr 28 after the bell.
TRIP: 61.36 (+0.82), EXPE: 108.79 (+0.77), MMYT: 21.78 (+0.43), PCLN: 1,465.87 (+1.87)

MakeMyTrip Limited to Report Fiscal 2016 Third Quarter Financial and Operating Results on January 28, 2016
Thomson Reuters ONE - Fri Jan 22, 3:16PM CST
New Delhi and New York, January 22, 2016. MakeMyTrip Limited (Nasdaq:MMYT), India's leading online travel company, plans to report its fiscal 2016 third quarter results before New York markets open on Thursday, January 28, 2016. The Company will post the release on its Investor Relations website: http://investors.makemytrip.com.
MMYT: 21.78 (+0.43)

Are Indian Stocks Safe, Post Fed Rate Hike & Global Worries?
Gourab Das - Zacks Investment Research - Fri Jan 15, 3:55PM CST
Amid concerns and counter arguments that the Indian markets have already factored in the rate hike impacts, we advise investors to be cautiously bullish
MMYT: 21.78 (+0.43), CTRP: 46.10 (+0.77), WNS: 29.80 (+0.25), MS: 32.24 (+0.32), TTM: 41.73 (+0.22)

Why Shares of Ctrip.com International Ltd. Exploded in 2015
Jeremy Bowman, The Motley Fool - Motley Fool - Fri Jan 15, 2:21PM CST
What: Shares of Ctrip.com International Ltd. were soaring through the roof last year, gaining 104%, according to data from S&P Capital IQ . The Chinese online travel agent rode a strong growth trend and delivered its own earnings beats to...
EXPE: 108.79 (+0.77), MMYT: 21.78 (+0.43), LONG: 18.00 (+0.11), CTRP: 46.10 (+0.77), PCLN: 1,465.87 (+1.87)

The Hottest Stock of 2016: MakeMyTrip?
Rick Munarriz, The Motley Fool - Motley Fool - Mon Jan 11, 1:00PM CST
Image source: MakeMyTrip. A dot-com laggard kicked off the new year as its biggest winner. Shares of MakeMyTrip -- India's leading online travel -- soared 29% last week. In an otherwise brutal week of sliding stock prices, MakeMyTrip took top...
MMYT: 21.78 (+0.43), CTRP: 46.10 (+0.77)

MakeMyTrip (MMYT) in Focus: Stock Moves 9% Higher
Zacks Equity Research - Zacks Investment Research - Mon Jan 11, 7:40AM CST
MakeMyTrip Limited (MMYT) saw its shares rise 9% in the last trading session.
MMYT: 21.78 (+0.43), BITA: 30.20 (+0.18)

Why MakeMyTrip, Mistras Group, and Silver Wheaton Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Thu Jan 07, 4:30PM CST
Mistras was a big winner today. Image: Mistras Group. On Thursday, the stock market returned to the gloom and doom that prevailed earlier in the week. Traders once again looked at the Chinese markets, and had concerns about a global macroeconomic...
MG: 24.87 (+0.16), SLW: 28.69 (-0.17), MMYT: 21.78 (+0.43), CTRP: 46.10 (+0.77)

MakeMyTrip Announces Investment by Ctrip
Thomson Reuters ONE - Thu Jan 07, 8:20AM CST
MakeMyTrip expects to use the capital to further strengthen its leadership in India's online travel markets
MMYT: 21.78 (+0.43), CTRP: 46.10 (+0.77)

BUYINS.NET: MOBI, WES, ISG, PSTI, HBANP, MMYT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Dec 29, 6:16AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Sky-mobi Ltd (NASDAQ:MOBI), Western Gas Partners LP (NYSE:WES), ING Groep NV (NYSE:ISG), Pluristem Therapeutics Inc (NASDAQ

STI), Huntington Bancshares Inc (NASDAQ:HBANP), MakeMyTrip Ltd (NASDAQ:MMYT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ISG: 26.09 (-0.03), IND: 24.99 (unch), HBAN: 9.88 (+0.15), PSTI: 1.62 (-0.02), MMYT: 21.78 (+0.43), WES: 50.46 (+0.46), MOBI: 2.05 (unch), HBANP: 1,440.00 (-10.00)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...